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Abstract Migration and proliferation of smooth muscle
cells (SMC) are important events during arteriogenesis, but
the underlying mechanism is still only partially understood.
The present study investigates the expression of integrins
a5b1 and vb3 as well as focal adhesion kinase (FAK) and
phosphorylated FAK (pY397), key mediators for cell
migration and proliferation, in collateral vessels (CV) in
rabbit hind limbs induced by femoral ligation or an arte-
riovenous (AV) shunt created between the distal femoral
artery stump and the accompanying femoral vein by con-
focal immunoﬂuorescence. In addition, the effect of the
extracellular matrix components ﬁbronectin (FN), laminin
(LN), and Matrigel on expression of these focal adhesion
molecules proliferation was studied in cultured SMCs. We
found that: (1) in normal vessels (NV), both integrins a5b1
and avb3 were mainly expressed in endothelial cells, very
weak in smooth muscle cells (SMC); (2) in CVs, both a5b1
and avb3 were signiﬁcantly upregulated (P\0.05); this
was more evident in the shunt-side CVs, 1.5 and 1.3 times
higher than that in the ligation side, respectively; (3) FAK
and FAK(py397) were expressed in NVs and CVs in a
similar proﬁle as was a5b1 and avb3; (4) in vitro SMCs
cultured on ﬁbronectin (overexpressed in collaterals)
expressed higher levels of FAK, FAK (pY397), a5b1, and
avb3 than on laminin, whereas SMCs growing inside
Matrigel expressed little of these proteins and showed no
proliferation. In conclusion, our data demonstrate for the
ﬁrst time that the integrin-FAK signaling axis is activated
in collateral vessels and that altered expression of FN and
LN may play a crucial role in mediating the integrin-FAK
signaling pathway activation. These ﬁndings explain a
large part of the positive remodeling that collateral vessels
undergo under the inﬂuence of high ﬂuid shear stress.
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Introduction
Arteriogenesis is a remodeling process of pre-existing
small arteriolar vessels into larger collateral vessels. One
main feature of collateral vessel growth is the neointima
formation. We previously reported that the cellular mech-
anism involved in neointima formation includes active
extracellular proteolysis, extracellular matrix remodeling,
smooth muscle cell proliferation, migration, and phenotype
changes [1–3]. Among these events, extracellular proteol-
ysis paves the way for smooth muscle migration, decreased
laminin is in favor of dedifferentiation of contractile
smooth muscle cells, whereas increased ﬁbronectin pro-
vides the trace for smooth muscle migration and also
facilitates smooth muscle proliferation. However, the out-
side-in or inside-out signal transduction events associated
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Integrins are a family of transmembrane receptors con-
sisting of an alpha and a beta chain that are the principle
mediators of cell interactions with the extracellular matrix
[4]. Integrin-ECM interactions play an important role in a
diverse variety of important biological processes [5].
The integrin a5b1 receptor mediates cell adhesion and
migration by recognition of ﬁbronectin, and provides pro-
liferative signals to vascular cells [6]. The vitronectin
receptors (VnR) v3 and v5 have been implicated in the
migration of a variety of cell types including smooth
muscle [7] and endothelial cells [8]. Furthermore, integrins
a5b1 and avb3 have been shown to be involved in ath-
erosclerosis, restenosis after angioplasty, and constrictive
vascular remodeling after injury [9]. Vascular injury
induces a5b1 integrin expression exclusively in prolifer-
ating VSMCs at the luminal surface of the neointima [10],
and VSMC invasion from the tunica media to the intima
has been shown to be dependent on avb3 integrin expres-
sion [11].
The nonreceptor tyrosin kinase focal adhesion kinase
(FAK) is a cytoplasmic protein that localizes to focal
contacts and adhesions which link to the extracellular
matrix. Its N-terminal FERM domain is important for
signal integration from growth factor receptors. Its C-ter-
minal FAT region contains binding sites for integrin-
associated proteins such as paxillin and talin. FAK is
activated by integrin clustering, also by various mechanical
stimuli and soluble factors, and is considered as a key
signal component at focal adhesions. FAK is expressed in
most tissues and cell types including vascular cells.
Recently, FAK was reported to be involved in blood vessel
morphogenesis and to regulate smooth muscle cell prolif-
eration and phenotype [12, 13].
Based on the information cited above, we hypothesized
that the FAK-integrin axis was activated during collateral
vessel growth. To test this hypothesis, we ﬁrst used im-
munoconfocal microscopy with speciﬁc antibodies to
determine the expression of FAK, FAK (pY397), and
integrins a5b1 and avb3 in collateral vessels in rabbit hind
limb induced by femoral ligation or by an arteriovenous
shunt created unilaterally between the distal stump of one
of the bilaterally occluded femoral arteries with the
accompanying vein. Next, we tested whether the induction
of expression of FAK, FAK (pY397), and integrins a5b1
and avb3 was in part mediated by extracellular matrix
components. For this purpose, we studied the effect of
ﬁbronectin, laminin and Matrigel (basement membrane
matrix) on expression of FAK, FAK (pY397), and integrins
a5b1 and avb3 in primary cultures of smooth muscle cells
by immunoconfocal microscopy. Our data showed that
FAK, FAK (pY397), and the integrins a5b1 and avb3 were
upregulated in growing collateral vessels, especially in
those induced by arteriovenous shunt and that ﬁbronectin,
laminin, and Matrigel had different impacts on the
expression of FAK, FAK (pY397), and integrins a5b1 and
avb3 in smooth muscle cells.
Methods
Animal model
The present study was performed with the permission of
the State of Hessen, Regierungspraesidium Darmstadt,
according to Sect. 8 of the German Law for the Protection
of Animals. All experimental protocols used in this research
project comply strictly with the Guide for the Care and Use
of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85–23, revised
1996). Eight adult New Zealand white rabbits were used in
this study. The animals were anesthetized with an i.m.
injection of midazolam (1 mg/kg) and xylazine (5 mg/kg),
and acute bilateral femoral artery ligation was performed
with two knots. Following immediate occlusion, an arte-
riovenous (AV) shunt was created unilaterally side-to-side,
between the distal femoral artery stump and the accom-
panying femoral vein. The simply ligated contralateral side
was used as control. Then the skin was closed with sterile
surgical clips. The animals were allowed to recover com-
pletely, and housed with free access to water and food. We
did not observe any gangrene or gross impairment of hind
limb function after femoral artery occlusion and arterio-
venous ﬁstula creation. All animals received antibiotic
(Bencylpenicillin) and analgesic treatment (Buprenorphin).
Tissue sampling
At day 7 post-surgery, the animals were re-anesthetized,
the collateral vessel tissues were removed and immediately
frozen in liquid nitrogen, embedded in tissue processing
medium (O C.T), and stored at -80C till further use. In
addition, the femoral artery and its branches from normal
rabbits without either ligation or shunt were used as normal
control. Total of 47 blood vessels, 12 normal arterioles, 16
collateral vessels from ligation only site, and 19 collateral
vessels from AV-shunt site were investigated.
Immunohistochemistry
Cryosections were cut 5-lm thick and ﬁxed in 4% para-
formaldehyde. For integrins a5b1 and avb3 staining
acetone ﬁxation was used, and then pre-incubated in 0.2%
BSA-C (Aurion Co.) and thereafter incubated with the
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123primary antibodies (Table 1). Incubation of secondary
antibodies (Donkey anti-mouse-IgG or anti-goat-IgG,
Dianova, Germany, at 1:200) was followed by Cy2 or Cy3
conjugated Streptavidin (Biotrend). The nuclei were
stained with 7-aminoactinomycin D or TOTO3 (Molecular
Probes). The sections were coverslipped and viewed with a
Leica confocal microscope (Leica TCS SP). Further doc-
umentation and image analysis were carried out using a
Silicon Graphics Octane workstation (Silicon Graphics)
and three-dimensional multichannel image processing
software (Bitplane).
Immunostaining for cultured cells was performed fol-
lowing a similar protocol as described above, except for
primary antibody incubation which was conducted at 4C
overnight.
Cell culture
We used primary cultures of rabbit aortic smooth muscle
cells (SMCs), which were isolated and cultivated as
described previously for porcine aortic SMCs [14]. Cells
were cultivated routinely in medium 199 (PAA; Coelbe,
Germany) with 20% FCS; when they reached conﬂuence
they were split 1:4. Cells between passage four and six
were used for the described experiments.
Culture of SMC on extracellular matrix material (ECM)
Plastic 12-well culture plates (Greiner; Frickendorf,
Germany) containing 18-mm round glass coverslips
were coated with either 5 lg/cm
2 laminin (BD Biosci-
ences) or 5 lg/cm
2 ﬁbronectin (BD Biosciences), for 1 h
at room temperature. Remaining material was aspirated
and the plates were rinsed carefully. SMCs were seeded on
top of the protein layer and incubated at 37C, 5% CO2
until they were 50–75% conﬂuent. For cell culture in
a three-dimensional matrix, SMCs were added to
150 ll/cm
2 Matrigel Basement Membrane Matrix (BD
Biosciences) as instructed by the manufacturer. Plates were
incubated for 30 min at 37C and cell culture medium was
added.
Cell proliferation in vitro
Cell proliferation of smooth muscle cells cultured on dif-
ferent substrates, FN, LN, and Matrigel Basement
Membrane Matrix was detected with 5-Bromo–20-deoxy-
uridine Labeling and Detection Kit 1 (Roche Diagnostics
GmbH, Germany) according to the manufacturer’s
protocol.
In all staining procedures, incubation with PBS instead
of the ﬁrst antibody was used as negative control to exclude
nonspeciﬁc binding of the secondary detection system.
Quantitative measurements
The quantiﬁcation of immunoﬂuorescence intensity was
performed with a Leica TCS SP confocal microscope,
using the quantitation software from Leica as described
previously [3]. Brieﬂy, one channel with format 512 and
appropriate ﬁlters was used. A full range of gray values
from black to peak white (0-pixel to 255-pixel intensity
level) was set during the whole process of measurements.
The intensity of ﬂuorescence was expressed as arbitrary
units AU/lm
2.
Quantitation of BrdU-positive cells was performed with
the confocal microscope. The counting was done at 409,
and the ratio of BrdU-positive nuclei to all nuclei of vas-
cular wall cells or smooth muscle cells was considered as
proliferation index.
All data are presented as mean ± SEM. ANOVA test
was used to examine the difference between normal vessels
and growing vessels.
Results
Expression of FAK and FAK(pY397) in vivo and
in vitro
In normal arterial vessels, endothelial cells expressed FAK,
but the majority of the media SMCs and adventitial cells
only weakly expressed FAK. FAK(pY397) was mainly
detected in endothelial cells. One week after surgery FAK
and FAK(pY397) were signiﬁcantly up-regulated in both
ligation and shunt-side collateral vessels. The increase in
shunt-side was more evident, being 1.3-fold and 1.5 fold
over that in only ligation side (Fig. 1a–c, Table 2). The
immunostaining of FAK and FAK(pY397) in serial sec-
tions revealed that increased expression of FAK was
accompanied by an increase of expression of FAK(pY397)
Fig. 1d–e).
We tested the possible role of the components of the
basement membrane in regulating the expression of FAK
and FAK (pY397) in smooth muscle cells. We found that
Table 1 Primary and secondary antibodies used in this study
Antigen Clone Host Dilution Company
Integrin avb3 LM609 Mouse 1:100 Chemicon
Integrin a5b1 IBS5 Mouse 1:100 Chemicon
FAK 77 Mouse 1:100 BD Transduction
FAK(pY397) 14 Mouse 1:100 BD Transduction
Anti-mouse-IgG Donkey 1:100 Dianova, Germany
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123smooth muscle cells cultured on ﬁbronectin substrate
highly expressed FAK and FAK (pY397), to a lesser
amount on Laminin substrate and very little inside a Ma-
trigel basement membrane matrix (Fig. 2a–f, Table 3).
Expression of integrins a5b1 and a5b1 in vivo and
in vitro
In normal arterial vessels, integrin a5b1 was faintly present
in all vascular cells but avb3 was only expressed in
endothelial cells. In growing collateral vessels, both
Fig. 1 Confocal micrographs
of FAK and FAK(pY397)
immunostaining in normal
(NV), control (only ligation)
(CLV), and AV-shunt (AV-S)
collateral vessels. a–d: FAK; e:
FAK(pY397). a: NV; b: CLV,
c, d and e: AV-S. Note that AV-
S showed strong staining for
both FAK and FAK(pY397). d
and e showing colocalization of
FAK and FAK(pY397) in serial
sections
Table 2 Quantitative analysis of immunoﬂuorescence density (AU/
lm
2) of FAK, FAK(py397), and integrins a5b1 and avb3 in normal
(NV), control (only ligation) (CLV), and AV-shunt vessels (1 week)
NV (N = 12) CLV (N = 16) AV-shunt (19)
FAK 66.31 ± 8.14 128.26 ± 8.30 166.32 ± 9.90*
FAK(pY397) 24.86 ± 4.11 54.09 ± 7.13 81.28 ± 3.74*
a5b1 43.15 ± 4.27 93.0 ± 7.93 136.75 ± 10.05*
avb3 23.53 ± 3.41 80.08 ± 4.83 105.28 ± 9.59*
1-way ANOVA test
* P\0.05 versus CLV or NV
Fig. 2 Confocal micrographs
of FAK and FAK(pY397)
immunostaining in smooth
muscle cells cultured on
different substances. F-actin
was stained by Rodamin-
labelled phalloidin. a–c: for
FAK; d–f: for FAK(pY397); a
and d: on ﬁbronectin; b and e:
on laminin; c and f: inside
Matrigel basement membrane
matrix. Note that ﬁbronectin
was the strongest stimulator of
expression of FAK and
FAK(pY397)
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123proteins were upregulated in the vascular wall. A more
marked expression was seen in shunt-side collateral vessels
(Fig. 3a–f). Integrin a5b1 was 1.5 times higher and avb3
1.3 times higher in shunt-side collateral vessels than in the
ligation side (Table 3). In vitro experiments with smooth
muscle cells cultured on ﬁbronectin substrate showed
strong staining for both integrins a5b1 and avb3, while on
laminin substrate, smooth muscle cells expressed less
integrins a5b1 and avb3. Inside the Matrigel basement
membrane matrix, smooth muscle cells expressed little
integrins a5b1 and avb3 (Fig. 4, Table 3).
Proﬁle of cell proliferation in vitro
A BrdU labeling test was performed in vitro in this study.
The index of cell proliferation in smooth muscle cells
on ﬁbronectin, laminin, and inside the Matrigel base-
ment membrane was 38%, 28%, and 0% (Fig. 5a–c),
respectively.
Discussion
Smooth muscle cells in the media are enveloped by a
basement membrane mainly composed of collagen IV and
laminin, preventing SMC from proliferation and migration
and keeping SMC in a contractile state [15–17]. We
demonstrated previously that active extracellular proteol-
ysis is present in the process of arteriogenesis, which
includes increased expression of MMP-2 and -9, degrada-
tion of the basement membrane and smooth muscle cell
migration resulting in neointima formation [2]. We also
found that ﬁbronectin is upregulated during arteriogenesis
[1]. In this study the molecular mechanisms by which the
extracellular matrix and intracellular signaling regulate
SMC migration were examined by analyzing the expres-
sion of focal adhesion kinase (FAK), and integrins a5b1
and avb3. The expression of phosphorylated FAK(pY397),
a marker for FAK activation, was also detected. The
phosphorylation at Tyr397 creates a high afﬁnity binding
site for the Src homology 2 domain of Src family kinases,
leading to a signaling complex between FAK and Src
family kinases [18, 19]. We found all these proteins
upregulated during arteriogenesis, and much more marked
in shunt-side collateral vessels, which indicates that the
FAK-integrin signaling axis was activated in the process of
collateral vessel growth.
The studies describing impairment of migration in FAK-
deﬁcient cells and its restoration by the reconstitution with
wild-type FAK [20] implicate that FAK plays an important
role in cell migration. Furthermore, intimal hyperplasia
correlated with overexpression of FAK in smooth muscle
cells[21],whereasoverexpressionofFRNK,anendogenous
Table 3 Quantitative analysis of immunoﬂuorescence density (AU/
lm
2) of FAK, FAK(py397), and integrins a5b1 and avb3 in SMC
cultured on different substances, ﬁbronectin (FN), laminin (LN),
Matrigel and without substance (C)
FN LN Matrigel
FAK 139.96 ± 14.68* 86.39 ± 9.66 35.48 ± 9.51
FAK(pY397) 74.81 ± 8.05* 40.97 ± 4.94 18.78 ± 8.06
a5b1 65.65 ± 7.86* 33.92 ± 5.08 6.95 ± 2.20
avb3 45.91 ± 4.06* 30.03 ± 2.91 8.57 ± 4.23
1-way ANOVA test
* P\0.05 versus LN or Matrigel
Fig. 3 Confocal micrographs
of a5b1 and avb3
immunostaining in normal
(NV), control (only ligation)
(CLV), and AV-shunt (AV-S)
collateral vessels. a–c:5 b1; d–f:
avb3; a and d: NV; b and e:
CLV, c and f: AV-S. Note that
AV-S showed strong staining
for both a5b1 and avb3
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smooth muscle cells [22]. Taken these ﬁndings together, our
data suggest that upregulation of FAK during arteriogenesis
may be crucial for smooth muscle cell migration and neo-
intima formation.
FAK can mediate cell motility and migration via inside-
out signaling mechanisms. Inhibition of FAK expression
led to inhibition of MMP-9 gene expression [23], whereas
MMP inhibitors augment ﬁbroblast adhesion through sta-
bilization of focal adhesion contacts [24]. It has been
suggested that FAK activation in an in vivo environment
may synchronize MMP-mediated extracellular proteolysis
and cell motility [23]. Fibronectin is an important com-
ponent of the extracellular matrix to facilitate cell
migration. A recent study shows that FAK promotes
organization of the ﬁbronectin matrix and ﬁbrillar adhe-
sions [25]. In growing collateral vessels, upregulation of
MMPs, ﬁbronectin, and FAK have been observed, there-
fore we hypothesize that smooth muscle cell migration is
partly regulated in arteriogenesis through a FAK inside-out
signaling mechanism.
Integrin a5b1 is mainly a ﬁbronectin-receptor. It medi-
ates most of ﬁbronectin’s biological activities, of which,
integrin a5b1 triggering by soluble or anchored ﬁbronectin
promotes cellular locomotion [26]. Its weak expression in
the media of normal arteries of rabbit hind limb is con-
sistent with the small amount of ﬁbronectin present in the
basement membrane, indicating that this receptor does not
play an important role in regulating the function of smooth
muscle cells in normal vessels. The induction and upreg-
ulation of integrin a5b1 observed after vascular injury, in
atherosclerosis and in ductus closure, suggest that it may be
involved in smooth muscle cell migration and proliferation,
contributing to blood vessel repair [10, 27]. Our novel
ﬁnding of dramatic upregulation of integrin a5b1 suggests
that this integrin plays an important role in collateral vessel
growth. The correlation of upregulation of integrin a5b1
with increased expression of ﬁbronectin [1], extracellular
proteolysis, neointima formation [2] and proliferation is in
accordance with the notion that integrin a5b1 is a factor for
cell migration and proliferation which is conﬁrmed by the
in vitro experiments of this study.
Fig. 4 Confocal micrographs
of a5b1 and avb3
immunostaining in SMC
cultured on different substances.
a–c: for a5b1; d–f: for avb3; a
and d: on ﬁbronectin; b and e:
on laminin; c and f: inside
Matrigel basement membrane
matrix. Note that ﬁbronectin
was the strongest stimulator of
expression of a5b1 and avb3.
Note also that cells on
ﬁbronectin expressed high
levels of a5b1 and avb3,
whereas these were lowest on
Matrigel
Fig. 5 Representative
micrographs of BrdU labeling in
smooth muscle cells cultured on
different substrates. a:o n
ﬁbronectin; b: on laminin; c:
inside Matrigel. Note that SMCs
cultured on ﬁbronectin showed
high proliferation, whereas
inside Matrigel there was no
proliferation
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123Integrin avb3 is mainly a vitronectin-receptor, but var-
ious other ligands have been documented. This receptor is
not present in adult smooth muscle cells, but is induced in
the neointima, media, and adventitia after vascular injury
[28], whereas the avb3 inhibiting RGD peptide, G-Pen-
GRGDSPCA, or XJ 735 (a selective cyclic Arg-Gly-Asp
(RGD) limit neointimal hyperplasia and lumen stenosis
[28, 29]. Recently, Choi et al. showed that this receptor
mediates intimal smooth muscle accumulation in the neo-
intima after carotid ligature in mice [30]. These studies
indicate that integrin avb3 plays an important role in reg-
ulating smooth muscle cell migration and proliferation.
Currently, the role of integrin vb3 in arteriogenesis is not
clear. Since integrin vb3 facilitating cell invasion [31], it
mediates SMC migration by stimulating SMC-MMP pro-
duction [32] and it regulates a5b1-mediated cell migration
toward ﬁbronectin [33], we suppose that the upregulated
integrin avb3 may be an important contributor to smooth
muscle cell migration and neointima formation.
Factors mediating expression of FAK and integrins 5b1
and vb3 in vascular cells currently remain to be deter-
mined. However, increasing body of evidence suggests the
underlying mechanism for these protein’s expression is
probably associated with increased blood ﬂow, upregula-
tion of growth factors and inﬂammation present in
collateral vessel. Firstly, shear stress and high intraluminal
pressure were reported to activate integrins and FAK and
up-regulate expression of FAK [34–36]. Secondly, both
FGF2 and PDGF BB increased integrin 5b1 expression in
cultured smooth muscle cells [10]. Furthermore FGF
increased expression of integrins vb3 in collateral vessels
[37]. VEGF activated integrin 5b1[ 38], and the synergism
between its receptors and integrins in angiogenesis was
also observed recently [39]. Thirdly, Stimulation of smooth
muscle cells with inﬂammatory cytokines increased inte-
grin 5b1 expression [40]. The present study adds to the
knowledge that that changes in extracellular matrix com-
ponents may be also responsible for regulation of
expression of FAK and integrins 5b1 and vb3 during ar-
teriogenesis, which will be discussed below.
FAK connects to growth factor receptors through FAK
FERM domain and to integrins through C-terminal domain.
It integrates growth-factor and integrin signals to promote
cell migration. Integrin clustering upon binding to extra-
cellular matrix components, such as FN, or growth factor
binding to their receptors results in activation of FAK [41].
Therefore, upregulation of growth factors and the integrins
a5b1and avb3 indicates an increase in ‘‘outside-in’’ sig-
naling during arteriogenesis. Different integrins on cells
interact with different ECM components; for example,
smooth muscle cells adhere to FN mainly through the inte-
grina5b1,while theyadheretolamininthrougha1b1,a2b1,
and a3b1. Because of the mechanism by which FAK is
activated and the fact that FN and the integrin a5b1 are
present in the media of normal arterial vessels at a very low
level, but highly upregulated in growing collateral vessels,
we hypothesize that the changes in ECM components, such
as increase in ﬁbronectin and decrease in laminin and col-
lagen IV may be involved in the production of the integrins
a5b1 and avb3 as well as of FAK and FAK(pY397) during
collateral vessel growth. Our data demonstrate that cells
cultured on ﬁbronectin proliferate at a higher rate and
express high level of the integrins a5b1 and avb3 as well as
ofFAKandFAK(pY397),whereascellsculturedonlaminin
proliferate at a low rate and express lower levels of integrins
and FAK and FAK(pY397). This is more evident in cells
growing inside Matrigel (a basement membrane protein
preparation which contains laminin and collagen IV). Here,
cells do not proliferate and express only very low levels of
integrins and FAK and FAK(pY397) indicating that extra-
cellular matrix components can differentially regulate
expression of integrins, FAK and FAK(pY397) as well as
smooth muscle cell proliferation. The effects of ﬁbronectin
and laminin on cell proliferation and activation of FAK are
consistent with previous reports. Morla et al. found cells
growing on FN had a higher proliferation rate than those on
LN. Hedin et al. found cells cultured on LN produced few
focal adhesions, and tyrosine phosphorylation of proteins
was less than in cells on FN [12, 42]. To our knowledge, we
present here the ﬁrst report using three-dimensional base-
ment membrane Matrigel to study cell-matrix adhesions.
Our ﬁndings from in vitro experiments can explain at
least in part the mechanism by which the integrins a5b1 and
avb3, FAK, and FAK(pY397) are present at a lower level
and smooth muscle cells do not proliferate in normal arterial
vessels, while they are upregulated and smooth muscle cells
have a higher rate of proliferation during collateral vessel
growth. In normal arterial vessels, smooth muscle cells are
surrounded by a layer of basement membrane which is rich
in laminin and collagen IV, but lacks ﬁbronectin. Therefore,
smooth muscle cells express few integrins and FAK and
FAK(pY397) and not proliferate. In growing collateral
vessels,lamininandcollagenIVundergodegradation,while
ﬁbronectin is induced in large amounts, resulting in upreg-
ulation of the integrins a5b1 and avb3 and in activation of
FAK and smooth muscle cell proliferation.
Taken together, our data contribute new information to
the mechanism for arteriogenesis by showing activation of
the integrin-FAK signaling axis in collateral vessels. This
activation, at least in part, is mediated by extracellular
matrix components facilitating smooth muscle cell prolif-
eration and migration.
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